0.06 - 0.06
0.06 - 0.24
8.7K / 3.59M (Avg.)
-1.55 | -0.04
Profitability reveals how effectively the business turns revenues into profits. Higher and improving margins or returns on capital suggest a durable competitive advantage, supporting a stronger intrinsic valuation.
-3.43%
Both companies show negative ROE. Martin Whitman would check if the entire market segment is distressed.
-1.83%
Both firms have negative ROA. Martin Whitman would investigate if the market environment is extremely challenging.
2.66%
Positive ROCE while CRN.AX is negative. John Neff would see if competitive strategy explains the difference.
12.11%
Gross margin above 1.5x CRN.AX's 6.68%. David Dodd would assess whether superior technology or brand is driving this.
5.31%
Positive operating margin while CRN.AX is negative. John Neff might see a significant competitive edge in operations.
-4.89%
Both companies run at a net loss. Martin Whitman would see if broader market headwinds persist.